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ing the relationship between FA status and cardiovascular 
disease ( 3 ). Furthermore, the availability of n-3 long-chain 
polyunsaturated fatty acids (LC-PUFAs) has been related to 
mental development in infants ( 4 ) as well as to the attenua-
tion of the decline of mental performance in the elderly ( 5 ). 
The n-6 LC-PUFA dihomo-  -linolenic acid and arachidonic 
acid and the n-3 LC-PUFA eicosapentaenoic acid are precur-
sors of eicosanoids with different biological effects ( 6 ). The 
determination of FA status has a pivotal role in clinical trials 
and cross-sectional studies ( 7–9 ) and is a valuable biomarker 
for the quality of consumed dietary fat ( 10 ). 
 Conventional methods for analyzing the FA composition 
in biological samples consist of several analytical steps and 
are, therefore, cumbersome and time consuming. Typi-
cally, a skilled chemist requires 2 days for analyzing 10–20 
samples ( 11 ). In the last years, different approaches are 
employed to overcome this disadvantage. Fast gas chro-
matographic techniques were introduced and optimized 
for fatty acid methyl ester (FAME) analyses and quantifi ca-
tion ( 11, 12 ), but sample preparation has been the time- 
and cost-expensive factor. Therefore, new approaches focus 
on simplifying and reducing sample preparation steps like 
lipid extraction, lipid separation, and FAME synthesis. 
Masood and Salem ( 11 ) developed a robotic transesterifi -
cation method for the analysis of FAs from total plasma lip-
ids. Akoto et al. ( 13 ) used direct thermal desorption to 
analyze the FA composition of whole blood and total plasma 
lipids. Methods for analysis of FAs composition of total 
plasma or whole blood lipids provide valuable information 
and are cost-effective alternatives to the complex and time-
consuming analysis of individual lipid fractions ( 1, 14–16 ). 
However, analyses of FA composition of individual lipid 
fractions are more suitable for the sensitive detection of 
intervention effects or metabolic relationships ( 17 ). 
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 The FA composition of cellular and plasma lipids is of 
major importance for many biological functions. Although 
limited by different turnover rates and widely differing 
contribution of individual lipid classes to total pools, there 
is generally a reasonable correlation between FA composi-
tion of cellular and of plasma lipids ( 1 ). In clinical studies 
and epidemiological observations, only blood is easily 
accessible for analysis and can be assessed in large num-
bers of subjects ( 2 ). Many studies have aimed at investigat-
 This work was supported fi nancially in part by NUTRIMENTHE (grant 
agreement n°: 212652). B. Koletzko is the recipient of a Freedom to Discover 
Award of the Bristol-Myers Squibb Foundation, New York, NY. 
 Manuscript received 3 August 2009 . 
 Published, JLR Papers in Press, August 4, 2009 
 DOI 10.1194/jlr.D000547 
 High-throughput analysis of fatty acid composition of 
plasma glycerophospholipids  
 Claudia  Glaser ,  Hans  Demmelmair, and  Berthold  Koletzko 1 
 Division of Metabolic Diseases and Nutritional Medicine, Dr. von Hauner Children’s Hospital, 
Ludwig-Maximilians-University of Munich, Lindwurmstr. 4, D-80337 Munich, Germany 
 Abbreviations: CE, cholesteryl ester; CV, coeffi cient of variation; 
FAME, fatty acid methyl ester; GC, gas chromatography; GP, glycero-
phospholipid; LC-PUFA, long-chain PUFA; PhL, phospholipid; TAG, 
triacylglycerol . 
 1 To whom correspondence should be addressed.  
  e-mail: offi ce.koletzko@med.uni-muenchen.de 
  The online version of this article (available at http://www.jlr.org) 
contains supplementary data in the form of one table and two fi gures. 
methods












Supplemental Material can be found at:
New achievements in FA analysis 217
nonfasting) were collected in EDTA-containing vacutainers 
(Sarstedt AG and Co., Nümbrecht, Germany). The plasma was 
separated by centrifugation (900 g, 5 min) and stored at   20°C 
until analysis. 
 New method 
 A total of 100 µl of plasma, 100 µl of internal standard B, and 
0.6 ml methanol (precooled to 5°C) were combined in glass 
tubes and shaken for 30 s. The precipitated proteins were sepa-
rated from the methanolic phase by centrifugation at 900  g for 5 
min. The methanolic supernatant, which contained mainly polar 
lipids, was transferred into another glass tube. Twenty-fi ve µl 
sodium methoxide solution were added to the supernatant, then 
the tubes were shaken while selective synthesis of methyl esters 
from GP FAs proceeded at room temperature. The reaction was 
stopped after 3 min by adding 75 µl methanolic HCl. FAMEs 
were extracted by adding 300 µl hexane and shaking the tubes 
for 30 s. The upper hexane phase, which contains the extracted 
GP FAMEs, was transferred into a 2 ml vial. The extraction was 
repeated and combined extracts were dried under nitrogen fl ow 
at room temperature. The dry residue was taken up in 50 µl 
hexane (containing 2 g/l BHT) for GC analysis. 
 To evaluate lipid compositions in the methanolic supernatant 
after plasma protein precipitation and to compare the recovery 
of PhLs in the methanolic supernatant with the the recovery of 
PhLs in Folch extracts (reference method), the supernatant was 
deposited on a TLC plate. Lipid classes were separated by TLC 
and FAs bound in the different lipids were converted to FAMEs 
by acid catalyzed transesterifi cation (see reference method). 
 To optimize base catalyzed transesterifi cation and FAME ex-
traction, a model sample containing 100 µl water (representing 
plasma), 100 µl internal standard B, and 100 µl octadecane stan-
dard (not participating in the reactions) was applied. The ratio of 
the peak areas of methyl pentadecanoate to octadecane was used as 
indicator for transesterifi cation as well as for extraction effi ciency. 
 Reference method 
 Folch extraction. To 250 µl of plasma, 100 µl of internal 
standard A was added, the lipids were extracted according to a 
modifi ed Folch method ( 23, 24 ) using chloroform/methanol 
(2:1, v/v), and the extracts were washed two times with NaCl solu-
tion (2% in water). The extracts were dried at 30°C under re-
duced pressure and taken up in 400 µl chloroform/methanol 
(1:1) for application on the TLC plate. 
 Lipid fraction separation by TLC, acid catalyzed transesterifi cation. 
N-heptane, diisopropyl ether, and acetic acid (60:40:3) were used 
as mobile phase for the separation of PhLs, NEFAs, TAGs, and 
CEs ( 24 ). The corresponding bands were scraped from the TLC 
plate, transferred into glass tubes and 1.5 ml methanolic HCl was 
added. The closed tubes were shaken for 30 s and heated to 85°C 
for FAME synthesis (45 min). After cooling to room temperature, 
samples were neutralized with carbonate buffer. For methyl ester 
extraction, 1 ml hexane was added. After centrifugation at 900  g 
for 5 min, the upper hexane phase was transferred into a further 
glass tube. The extraction was repeated and combined extracts 
were taken to dryness under nitrogen fl ow at room temperature. 
The dry residue was taken up in 50 µl hexane (containing 2 g / l 
BHT) for GC analysis. 
 Chromatography 
 Individual FAMEs were quantifi ed by GC with fl ame ionization 
detection. GC analysis was carried out on a BPX 70 column 
(25 m × 0.22 mm, 0.25 µm fi lm, SGE, Weiterstadt, Germany) using 
an Agilent 5890 series II gas chromatograph (Agilent, Waldbronn, 
 We aimed to develop a method that is both sensitive, 
especially for the measurement of changes in plasma 
LC-PUFA content, and cost effective. For studies focusing 
on LC-PUFAs, it seems most promising to analyze plasma 
phospholipids (PhL s), because they contain higher per-
centages of LC-PUFAs and are less sensitive to short term 
variation than plasma triacylglycerols (TAGs) and choles-
teryl esters (CEs) ( 18, 19 ). For the determination of PhL 
FA in biological samples, Bondia-Pons et al. ( 12 ) presented 
an optimized method for lipid extraction and lipid separa-
tion using solid phase extraction instead of TLC. Their 
sample preparation technique is easier than those of 
established methods, but it is still very time consuming. 
 The term phospholipid is used for all lipids with a phos-
phorus-containing polar head group. PhLs can be further 
subdivided in glycerophospholipids (GPs) and SMs, based 
on their glycerole or sphingoid base backbone, respectively. 
The major PhL fractions in plasma are glycerophosphocho-
lines and SMs ( 20, 21 ). Although LC-PUFA percentages are 
high in glycerophosphocholines and other GPs, LC-PUFAs 
contribute less than 5% to the FAs esterifi ed to sphin-
gosine in SMs ( 20, 22 ). The contribution of SMs to total 
plasma PhL varies widely in healthy controls and in pa-
tients suffering from coronary artery disease ( 21 ). Thus, a 
further source of variation in LC-PUFA percentages can 
be eliminated by determining selectively the FA composi-
tion of GPs while excluding SMs from FA analysis. 
 To the best of our knowledge, no method has been 
described for determination of plasma GP FAs, avoiding 
cumbersome lipid extraction steps and preparative chro-
matographic isolation of lipid fractions. We developed a 
high-throughput method for the determination of the FA 
composition of plasma GPs by eliminating labor intensive 
procedures and compared our newly developed method 
with an established reference method. 
 MATERIALS AND METHODS 
 Reagents and samples 
 Solvents were obtained in the highest available purity from 
Merck KGaA (Darmstadt, Germany). Methanolic HCl (3 N) and 
sodium methoxide (25 wt. % in methanol) were purchased from 
Sigma-Aldrich (Taufkirchen, Germany). Two internal standards 
were applied. For internal standard A, pentadecanoic acid, 
cholesteryl pentadecanoate, tripentadecanoin, and 1,2-dipenta-
decanoyl-sn-glycero-3-phosphocholine (Sigma-Aldrich) were dis-
solved in methanol/chloroform (35:15). The internal standard 
B consisted of 1,2-dipentadecanoyl-sn-glycero-3-phosphocholine 
dissolved in methanol. For the determination of the effi ciency of 
base catalyzed transesterifi cation octadecane (Sigma-Aldrich) 
dissolved in methanol was used as internal standard. To prevent 
FA oxidation, 2 g/l 2.6-di- tert -butyl- p -cresol (butylated hydroxy-
toluene, BHT, Sigma-Aldrich) was added to each internal stan-
dard. GLC-85, containing 32 fatty acid methyl esters, (Nu-Check 
Prep, Inc., Elysian, MN) was applied as external standard. SM 
(chicken egg yolk,   98% TLC ) was purchased from Sigma- 
Aldrich. A mixture of sodium carbonate, sodium hydrogen car-
bonate, and sodium sulfate (1:2:2, Merck KGaA) was applied as 
buffer for neutralization after acid catalyzed transesterifi cation. 
Thirty-three blood samples from healthy volunteers (fasting and 
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precipitated with the protein; and  2 ) base catalyzed trans-
esterifi cation at room temperature: FAMEs were formed 
from GPs and the very small quantities of TAGs, (which 
were not precipitated with the protein), whereas no FAMEs 
were formed from NEFAs or FAs bound in SMs and CEs 
under these conditions. 
 To examine the effi ciency of the fi rst separation step, 
we compared the lipid composition of 16 different plasma 
samples obtained by the reference method with the lipid 
composition in the methanolic supernatant. The lipid com-
position was estimated by the sum of FAs determined in the 
individual lipid fractions. According the reference method, 
PhLs contributed 37.7%–54.6%, NEFAs 1.3%–3.7%, TAGs 
15.4%–35.8%, and CEs 23.6%–32.4% to total extracted lip-
ids. The lipid composition in the methanolic supernatant 
after protein precipitation and TLC was 90.9%–96.8% PhLs, 
1.3%–6.3% NEFAs, 0.9%–2.5% TAGs, and 0.8%–2.0% CEs. 
The use of 7 vols of methanol to volume of plasma was found 
to be optimal for dissolving PhLs quantitatively. The recov-
ery of total PhLs (n = 16) in the methanolic supernatants was 
found to be 88.1%  ± 6.6% (mean ± SD) compared with the 
reference method (Folch extraction). Direct addition of 
internal standard B to the plasma enabled correction for the 
loss of PhLs, thus 101.0% ± 2.6% of PhLs were correctly 
determined in the methanolic supernatants. 
 The total PhL (GP + SM) FA concentration for these 16 
samples was, on average, 1317.4 mg/l (1054.2 mg/l–1908.3 
mg/l), according to the reference method. The new 
method identifi ed in total 1229.9 mg/l (970.4 mg/l–1836.3 
mg/l) FAs in plasma GPs. 
 Hydrolysis of methyl esters was a concern, as water (from 
plasma sample) was present during base catalyzed transes-
terifi cation. Therefore, we studied reaction yields in a 
methanolic solution containing 100 µl of water and 100 µl 
of internal standard B. Reaction times between 3 min and 
10 min ensured complete transesterifi cation of GP FAs. 
The recovery of the internal standard B was 99.1% ± 0.8% 
(mean ± SD) relative to the octadecane standard in eight 
independent analyses. 
 After base catalyzed transesterifi cation, FAMEs were ex-
tracted twice with 300 µl hexane. To evaluate extraction 
effi ciency, samples were reextracted with 1 ml hexane. 
These extracts contained less than 1% of the total FAMEs 
recovered with the previous extractions. 
 Storage of the GC ready derivatives for one month at 
  20°C revealed no signifi cant alterations in FA concentra-
tions (data not shown). 
 Intra-assay reproducibilities (n = 8) obtained by the 
analysis of PhLs with the reference method were compared 
with those obtained by the analysis of GPs with the new 
method. FA concentrations (mg/l) and compositions (% 
wt/wt) were comparable, but concentrations of the satu-
rated FAs C20:0, C22:0, and C24:0 and of the monounsatu-
rated FA C24:1n-9 were below the quantifi cation level in 
GPs ( Table 1 ). GP total FA concentration was about 10% 
lower than in PhLs, whereas some individual FAs showed 
higher concentrations. For GPs, CVs for all FAs were found 
to be below 4%; C18:3n-3, contributing only 0.21% to total 
FAs, had the highest CV (3.8%). 
Germany) with an optimized temperature program starting at 
150°C. Without initial hold, temperature was increased by 2.5°C 
per min to 180°C and then with 1.5°C per min to 200°C followed 
by an 1-min isothermal period, allowing a total run time of only 
26.33 min. The pressure program (carrier gas He) started with an 
initial column head pressure of 0.9 bar, which was increased by 
0.02 bar per min to 1.2 bar, with 0.05 bar per min to 1.5 bar and 
0.1 bar per min to the fi nal pressure of 2.0 bar. 
 Data quantitation 
 Individual FAMEs were identifi ed by comparison with authen-
tic standards. For each FAME, the response relative to pentade-
canoic acid methyl ester (internal standard) was determined 
using GLC-85 as external standard. EZChrom Elite version 3.1.7 
(Agilent) was used for peak integration. 
 Statistical analysis 
 For FAs with a chain length between 14 and 24 carbon atoms, 
the results were expressed as absolute concentrations (mg/l 
plasma) and as percentages (% wt/wt). The FA data were pre-
sented as mean ± SD. As a measure of analytical precision, coef-
fi cients of variation (CV) expressed as percentages were used. 
Correlations were evaluated using the two-sided Spearman test 
and paired  t -tests were used for comparisons between mean val-
ues ( P < 0.05 was considered statistically signifi cant). All statistical 
analyses were performed with SPSS for Windows, Version 15.0.1 
(SPSS Inc., Chicago, IL). 
 RESULTS 
 Individual FAMEs were analyzed by GC. For specifi c 
analyses of GP FA compositions, a new method was devel-
oped, which allowed the selective formation of FAMEs 
from GPs. This was achieved by two simple steps ( Fig. 1 ):  1 ) 
Protein precipitation with methanol: separation of polar 
lipids [PhLs (GPs + SMs) and NEFAs], which were dis-
solved in the methanolic supernatant, from non polar lip-
ids [TAGs and CEs], which were almost quantitatively 
 Fig.  1. Lipids recovered from a plasma sample (estimated from 
total FAs in corresponding fractions) with different analysis meth-
ods or at different steps of the method, respectively. A: lipid com-
position of a plasma extract obtained by the reference method 
[solid dark gray, CEs (cholesteryl esters); striped gray, GPs (glycero-
phospholipids) (+ SM); light gray, NEFAs, and black, TAGs (triacyl-
glycererols)]; all lipid fractions were extracted. B: Lipid composition 
after the fi rst step of the new method (protein precipitation with 
methanol), mainly polar lipids were dissolved in the methanolic 
supernatant. C: Lipid composition after the second step of the new 
method (base catalyzed transesterifi cation), only GP and TAG fatty 
acids were transesterifi ed to fatty acid methyl esters. 
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anol. Due to their amphiphilic character, PhLs were easily 
soluble in methanol. The advantage of methanol precipi-
tation combined with subsequent base catalyzed transes-
terifi cation was that TAGs and CEs were dissolved in 
methanol only in negligible amounts, contributing less 
than 2.5% to the total FA in the methanolic supernatant, 
and NEFAs, SM FAs, as well as CE FAs were not converted 
to FAMEs by reaction with sodium methoxide at room 
temperature, as previously shown ( 25–27 ). Thus, only two 
simple steps were required to convert selectively GP FAs to 
FAMEs for GC analysis. 
 In an alkaline milieu, hydrolysis of synthesized methyl 
esters must be inhibited by neutralization of the reaction 
mixture, thus, the reaction was stopped after 3 min by add-
ing methanolic HCl to the mixture. A reaction time of 3 
min was suffi cient for complete transesterifi cation of GP 
FAs, but also a reaction time of 10 min yielded complete 
transesterifi cation without saponifi cation. This was in 
agreement with previous observations, which showed base 
catalyzed transesterifi cation to be about 1,500 times faster 
than saponifi cation ( 25, 26 ). 
 Results showed that C20:0, C22:0, C24:0, and C24:1n-6 
were present in PhLs but not in GPs, as these FAs were 
mainly bound in SMs and, therefore, not transesterifi ed to 
FAMEs. This was in agreement with the previously shown 
high abundance of these FAs in SMs, as about 95% of the 
SM FAs were saturated or monounsaturated ( 22 ). High per-
centages of LC-PUFAs were found in GPs, especially glycero-
 Inter-assay reproducibility ( Table 2 ) of the new method 
was obtained by analyzing 49 aliquots of one plasma sam-
ple over a period of 4 months. CVs for all FAs contributing 
more than 1% to total FAs were found to be below 4%. 
Values of C18:3n-6, contributing 0.10% to total FAs, 
showed the highest CV (10.9%). The FA contents re-
mained constant over 4 months. 
 FA concentrations and percentage contributions in PhLs 
obtained by the reference method were correlated with 
those in GPs obtained with the new method (see supple-
mentary Table I). For concentrations of all analyzed FAs 
(except C14:0 and C18:3n-6) in PhLs and GPs, correlation 
coeffi cients higher than 0.9 ( P < 0.0001) were observed. 
Both C14:0 and C18:3n-6 showed very low concentrations, 
and their contribution to total FAs in PhLs and GPs was 
below 1%, respectively. Percentage contributions of most 
FAs in PhLs and in GPs correlated with  r > 0.9 ( P < 0.0001). 
Only for C14:0, C20:1n-9, C22:4n-9, and C18:3n-3, lower
 r -values, between 0.76 and 0.89 ( P   0.001), were observed. 
 DISCUSSION 
 The new method enabled rapid, precise, and 
reproducible analysis of FA composition of plasma GPs 
 Plasma proteins were precipitated by adding methanol 
to plasma. TAGs and CEs dissolve poorly in polar solvents 
such as methanol. NEFAs showed better solubility in meth-
 TABLE 1. Intra-assay reproducibility  (n  = 8 ) of fatty acid concentration (mg/l) and composition (%) 
in phospholipids (PL) obtained by the reference method and in glycerophospholipids (GP) obtained by the 
new method, mean (CV) 
FA Concentration (mg/l) FA Composition (% wt./wt.)
FA PhL GP PhL GP
Saturated FA
 C14:0 5.24 (2.4) 7.95 (3.2) 0.40 (3.0) 0.65 (3.4)
 C16:0 368.36 (0.8) 354.78 (0.7) 27.96 (0.3) 28.85 (0.6)
 C17:0 5.37 (1.3) 4.93 (1.4) 0.41 (0.7) 0.40 (0.6)
 C18:0 185.00 (1.5) 168.46 (1.1) 14.04 (0.9) 13.70 (0.7)
 C20:0 6.67 (1.4) ND 0.51 (1.1) ND
 C22:0 15.64 (1.5) ND 1.19 (1.4) ND
 C24:0 14.11 (2.7) ND 1.07 (2.6) ND
Monounsaturated FA
 C16:1n-7 9.85 (1.5) 14.05 (2.0) 0.75 (1.7) 1.14 (1.8)
 C18:1n-7 19.88 (1.4) 20.69 (1.0) 1.51 (0.6) 1.68 (0.6)
 C18:1n-9 143.35 (1.0) 156.59 (1.3) 10.88 (0.5) 12.73 (0.7)
 C20:1n-9 2.35 (1.5) 2.26 (2.3) 0.18 (1.6) 0.18 (2.6)
 C24:1n-9 28.89 (1.2) ND 2.19 (0.8) ND
n-9 PUFA
 C20:3n-9 2.64 (2.9) 2.76 (1.9) 0.20 (2.3) 0.22 (1.8)
n-6 PUFA
 C18:2n-6 248.15 (1.1) 251.05 (1.4) 18.84 (0.8) 20.41 (0.7)
 C18:3n-6 1.73 (8.0) 2.15 (2.5) 0.13 (8.5) 0.17 (2.4)
 C20:2n-6 3.78 (1.7) 3.96 (1.9) 0.29 (1.5) 0.32 (1.3)
 C20:3n-6 43.25 (1.3) 41.59 (1.3) 3.28 (0.6) 3.38 (0.7)
 C20:4n-6 133.09 (1.2) 124.89 (1.3) 10.10 (0.4) 10.15 (0.8)
 C22:4n-6 5.41 (1.5) 4.64 (2.6) 0.41 (1.4) 0.38 (2.0)
 C22:5n-6 4.08 (3.2) 3.70 (2.5) 0.31 (3.2) 0.30 (2.1)
n-3 PUFA
 C18:3n-3 1.92 (2.5) 2.59 (3.8) 0.15 (2.1) 0.21 (3.7)
 C20:5n-3 10.50 (1.3) 9.99 (1.6) 0.80 (0.6) 0.81 (0.7)
 C22:5n-3 12.00 (1.1) 10.69 (1.5) 0.91 (0.6) 0.87 (0.9)
 C22:6n-3 46.22 (1.9) 42.15 (1.4) 3.51 (1.1) 3.43 (0.9)
Total FA
1317.42 (0.9) 1229.85 (0.9)
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in TAGs and PhLs correlated and, thus, the infl uence of 
those residues on compositional results was limited ( 30 ). 
 Our new sample preparation technique enables the 
analysis of FA composition of plasma glycerophospholip-
ids from more than 50 samples per day. Throughput is lim-
ited by the running time of the GC, which takes 26.33 min 
for each sample. It provides results equivalent to 
the analysis of PhL FAs by the reference method and is 
espe cially suitable for the determination of long-chain 
unsaturated fatty acids, which are mainly bound in glycero-
phospholipids. The easy handling allows reproducible and 
robust analyses and enables the use of FA concentrations 
as biomarkers in large clinical and epidemiological stud-
ies.  
 The new method for the analysis of glycerophospholipid fatty 
acid composition in plasma described in this article is in patent-
pending status. The presented data are part of a PhD thesis 
accomplished by Claudia Glaser at the Medical Faculty of the 
Ludwig-Maximilians-University of Munich. 
 REFERENCES 
  1 .  Baylin ,  A. ,  M. K.  Kim ,  A.  Donovan-Palmer ,  X.  Siles ,  L.  Dougherty ,  P. 
 Tocco , and  H.  Campos .  2005 .  Fasting whole blood as a biomarker 
of essential fatty acid intake in epidemiologic studies: comparison 
with adipose tissue and plasma.  Am. J. Epidemiol.  162 :  373 – 381 . 
phosphoethanolamine and glycerophosphoserine but also 
in glycerophosphocholine ( 22, 28 ). Total GP FA concentra-
tion was about 10% lower than PhL FA concentrations be-
cause SM FAs were not transesterifi ed and, therefore, were 
not assessed with the new method. Some individual FAs 
showed higher concentrations in GPs, which could be due 
to small contaminations with TAGs. Furthermore, Folch ex-
traction has been shown to be nonquantitative in extracting 
lipids from plasma ( 29 ). 
 Results for GP FAs could not be directly compared with 
results for PhL FAs because PhL FAs contained additional 
SM FAs and so differing FA compositions were obtained. 
Nevertheless, comparison of results for PhL FAs obtained 
by the reference method with results for GP FAs obtained 
by the new method showed high correlations. 
 The LC-PUFA content of plasma glycerophosphocho-
line, which was by far the most abundant plasma GP, has 
been found to be similar to red blood cell glycerophospho-
choline LC-PUFA content ( 17 ). Thus, it can be expected 
that GP FA composition was representative for the FA sta-
tus in a variety of physiological and pathological condi-
tions. As shown by the very good correlation between the 
FA composition of PhLs obtained by the reference method 
and the FA composition of the GP obtained by the new 
method, the small amount of TAGs contributing to the 
analyzed FAs did not disturbed the results. Furthermore, 
the percentage contribution of individual FAs to total FAs 
 TABLE 2. Inter-assay reproducibility ( n  = 49) of fatty acid concentrations (mg/l) and compositions (% wt./wt.) 
in glycerophospholipids analyzed over a time period of 4 months with at least two measurements per week with 
the new method 
FA Concentration FA Composition
FA Mean CV Mean CV
Saturated FA
 C14:0 7.29 3.5 0.60 3.2
 C16:0 378.91 2.1 31.32 1.5
 C17:0 4.63 3.3 0.38 2.6
 C18:0 167.85 4.0 13.87 2.7
 C20:0 ND ND ND ND
 C22:0 ND ND ND ND
 C24:0 ND ND ND ND
Monounsaturated FA
 C16:1n-7 12.18 2.9 1.01 2.3
 C18:1n-7 21.46 3.0 1.77 1.7
 C18:1n-9 152.91 3.0 12.64 1.2
 C20:1n-9 2.16 6.8 0.18 5.4
 C24:1n-9 ND ND ND ND
n-9 PUFA
 C20:3n-9 2.39 7.8 0.20 7.2
n-6 PUFA
 C18:2n-6 244.26 2.8 20.19 1.0
 C18:3n-6 1.26 10.9 0.10 10.5
 C20:2n-6 4.48 4.4 0.37 3.3
 C20:3n-6 38.68 4.0 3.20 2.4
 C20:4n-6 108.31 4.3 8.95 3.0
 C22:4n-6 3.68 9.5 0.30 8.7
 C22:5n-6 4.14 7.6 0.34 6.7
n-3 PUFA
 C18:3n-3 2.73 4.2 0.23 3.3
 C20:5n-3 7.19 7.6 0.59 6.6
 C22:5n-3 7.90 7.1 0.65 6.1
 C22:6n-3 37.56 3.8 3.10 2.8
Total FA
1221.34 2.5












Supplemental Material can be found at:
New achievements in FA analysis 221
  2 .  Hodge  A. M. ,  D. R.  English , K. O’Dea, A. J. Sinclair, M. Makrides, 
R. A. Gibson, and G. G. Giles.  2007 .  Plasma phospholipid and dietary 
fatty acids as predictors of type 2 diabetes: interpreting the role of 
linoleic acid.  Am. J. Clin. Nutr.  86 :  189 – 197 . 
  3 .  Getz ,  G. S. , and  C. A.  Reardon .  2007 .  Nutrition and cardiovascular 
disease.  Arterioscler. Thromb. Vasc. Biol.  27 :  2499 – 2506 . 
  4 .  Fleith ,  M. , and  M. T.  Clandinin .  2005 .  Dietary PUFA for preterm 
and term infants: review of clinical studies.  Crit. Rev. Food Sci. Nutr. 
 45 :  205 – 229 . 
  5 .  Cole ,  G. M. ,  G. P.  Lim ,  F.  Yang ,  B.  Teter ,  A.  Begum ,  Q.  Ma ,  M. E. 
 Harris-White , and  S. A.  Frautschy .  2005 .  Prevention of Alzheimer’s 
disease: omega-3 fatty acid and phenolic anti-oxidant interventions. 
 Neurobiol. Aging .  26 ( Suppl 1 ):  133 – 136 . 
  6 .  Schmitz ,  G. , and  J.  Ecker .  2008 .  The opposing effects of n-3 and n-6 
fatty acids.  Prog. Lipid Res.  47 :  147 – 155 . 
  7 .  Chavarro ,  J. E. ,  M. J.  Stampfer ,  H.  Li ,  H.  Campos ,  T.  Kurth , and  J. 
 Ma .  2007 .  A prospective study of polyunsaturated fatty acid levels in 
blood and prostate cancer risk.  Cancer Epidemiol. Biomarkers Prev.  16 : 
 1364 – 1370 . 
  8 .  Albert ,  C. M. ,  H.  Campos ,  M. J.  Stampfer ,  P. M.  Ridker ,  J. E. 
 Manson ,  W. C.  Willett , and  J.  Ma .  2002 .  Blood levels of long-chain 
n-3 fatty acids and the risk of sudden death.  N. Engl. J. Med.  346 : 
 1113 – 1118 . 
  9 .  von Schacky ,  C.  2007 .  Omega-3 fatty acids and cardiovascular dis-
ease.  Curr. Opin. Clin. Nutr. Metab. Care .  10 :  129 – 135 . 
 10 .  Baylin ,  A. , and  H.  Campos .  2006 .  The use of fatty acid biomarkers 
to refl ect dietary intake.  Curr. Opin. Lipidol.  17 :  22 – 27 . 
 11 .  Masood ,  M. A. , and  N.  Salem ,  Jr .  2008 .  High-throughput analysis 
of plasma fatty acid methyl esters employing robotic transesterifi ca-
tion and fast gas chromatography.  Lipids .  43 :  171 – 180 . 
 12 .  Bondia-Pons ,  I. ,  S.  Morera-Pons ,  A. I.  Castellote , and  M. C.  Lopez-
Sabater .  2006 .  Determination of phospholipid fatty acids in biologi-
cal samples by solid-phase extraction and fast gas chromatography. 
 J. Chromatogr. A .  1116 :  204 – 208 . 
 13 .  Akoto ,  L. ,  R. J.  Vreuls ,  H.  Irth ,  R.  Pel , and  F.  Stellaard .  2007 .  Fatty 
acid profi ling of raw human plasma and whole blood using direct 
thermal desorption combined with gas chromatography-mass spec-
trometry.  J. Chromatogr. A .  1186 :  365 – 371 . 
 14 .  Bailey-Hall ,  E. ,  E. B.  Nelson , and  A. S.  Ryan .  2008 .  Validation 
of a rapid measure of blood PUFA levels in humans.  Lipids .  43 : 
 181 – 186 . 
 15 .  Harris ,  W. S. , and  C.  von Schacky .  2004 .  The Omega-3 Index: a new 
risk factor for death from coronary heart disease?  Prev. Med.  39 : 
 212 – 220 . 
 16 .  Uauy ,  R. ,  P.  Mena ,  B.  Wegher ,  S.  Nieto , and  N.  Salem ,  Jr .  2000 .  Long 
chain polyunsaturated fatty acid formation in neonates: effect of ges-
tational age and intrauterine growth.  Pediatr. Res.  47 :  127 – 135 . 
 17 .  Rise ,  P. ,  S.  Eligini ,  S.  Ghezzi ,  S.  Colli , and  C.  Galli .  2007 .  Fatty acid 
composition of plasma, blood cells and whole blood: relevance for 
the assessment of the fatty acid status in humans.  Prostaglandins 
Leukot. Essent. Fatty Acids .  76 :  363 – 369 . 
 18 .  Callow ,  J. ,  L. K.  Summers ,  H.  Bradshaw , and  K. N.  Frayn .  2002 . 
 Changes in LDL particle composition after the consumption of 
meals containing different amounts and types of fat.  Am. J. Clin. 
Nutr.  76 :  345 – 350 . 
 19 .  Skeaff ,  C. M. ,  L.  Hodson , and  J. E.  McKenzie .  2006 .  Dietary-
induced changes in fatty acid composition of human plasma, plate-
let, and erythrocyte lipids follow a similar time course.  J. Nutr.  136 : 
 565 – 569 . 
 20 .  Dougherty ,  R. M. ,  C.  Galli ,  A.  Ferro-Luzzi , and  J. M.  Iacono .  1987 . 
 Lipid and phospholipid fatty acid composition of plasma, red blood 
cells, and platelets and how they are affected by dietary lipids: a 
study of normal subjects from Italy, Finland, and the USA.  Am. J. 
Clin. Nutr.  45 :  443 – 455 . 
 21 .  Jiang ,  X. C. ,  F.  Paultre ,  T. A.  Pearson ,  R. G.  Reed ,  C. K.  Francis ,  M. 
 Lin ,  L.  Berglund , and  A. R.  Tall .  2000 .  Plasma sphingomyelin level 
as a risk factor for coronary artery disease.  Arterioscler. Thromb. Vasc. 
Biol.  20 :  2614 – 2618 . 
 22 .  Phillips ,  G. B. , and  J. T.  Dodge .  1967 .  Composition of phospholip-
ids and of phospholipid fatty acids of human plasma.  J. Lipid Res.  8 : 
 676 – 681 . 
 23 .  Folch ,  J. ,  M.  Lees , and  G. H.  Sloane Stanley .  1957 .  A simple method 
for the isolation and purifi cation of total lipides from animal tis-
sues.  J. Biol. Chem.  226 :  497 – 509 . 
 24 .  Carnielli ,  V. P. ,  F.  Pederzini ,  R.  Vittorangeli ,  I. H.  Luijendijk ,  W. E. 
 Boomaars ,  D.  Pedrotti , and  P. J.  Sauer .  1996 .  Plasma and red blood 
cell fatty acid of very low birth weight infants fed exclusively with 
expressed preterm human milk.  Pediatr. Res.  39 :  671 – 679 . 
 25 .  Carrapiso ,  A. I. , and  C.  Garcia .  2000 .  Development in lipid analy-
sis: some new extraction techniques and in situ transesterifi cation. 
 Lipids .  35 :  1167 – 1177 . 
 26 .  Suter ,  B. ,  K.  Grob , and  B.  Pacciarelli .  1997 .  Determination of fat 
content and fatty acid composition through 1-min transesterifi ca-
tion in the food sample; principles.  Z. Lebensm. Unters. Forsch.  204 : 
 252 – 258 . 
 27 .  Christie ,  W. W.  1982 .  A simple procedure for rapid transmethylation 
of glycerolipids and cholesteryl esters.  J. Lipid Res.  23 :  1072 – 1075 . 
 28 .  Trebble ,  T. ,  N. K.  Arden ,  M. A.  Stroud ,  S. A.  Wootton ,  G. C. 
 Burdge ,  E. A.  Miles ,  A. B.  Ballinger ,  R. L.  Thompson , and  P. C. 
 Calder .  2003 .  Inhibition of tumour necrosis factor-alpha and inter-
leukin 6 production by mononuclear cells following dietary fi sh-oil 
supplementation in healthy men and response to antioxidant co-
supplementation.  Br. J. Nutr.  90 :  405 – 412 . 
 29 .  Lepage ,  G. , and  C. C.  Roy .  1986 .  Direct transesterification 
of all classes of lipids in a one-step reaction.  J. Lipid Res.  27 : 
 114 – 120 . 
 30 .  Geppert ,  J. ,  H.  Demmelmair ,  G.  Hornstra , and  B.  Koletzko . 
 2008 .  Co-supplementation of healthy women with fi sh oil and 
evening primrose oil increases plasma docosahexaenoic acid, 
gamma-linolenic acid and dihomo-gamma-linolenic acid levels 
without reducing arachidonic acid concentrations.  Br. J. Nutr. 
 99 :  360 – 369 . 












Supplemental Material can be found at:
